Computational Geeks Uncovered a Therapy for Cancer
It's called the 'kiss of death'. Triple-negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple-negative breast cancer is aggressive and deadly. Patients are currently treated by chemotherapy but there is no guarantee of success—and unfortunately, for those that chemotherapy does not work, the survival rate remains only 12 months.